Safety assessment of a hydroethanolic extract of caralluma fimbriata

International Journal of Toxicology

Volumn 32, Issue 5, 2013, Pages 385-394

  Odendaal, Antoinette Y ^a   Deshmukh, Narendra S ^b   Marx, Tennille K ^a   Schauss, Alexander G ^a   Endres, John R ^a   Clewell, Amy E ^a  

^a AIBMR Life Sciences Inc   (United States)

^b Intox Pvt Ltd   (India)

Author keywords

and developmental toxicity studies; appetite suppressant; Caralluma fimbriata; chronic; genotoxicity; NOEL; safety assessment

Indexed keywords

ALCOHOL; CARALLUMA FIMBRIATA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

AMES TEST; ANIMAL EXPERIMENT; ARTICLE; CHROMOSOME ABERRATION; CHRONIC TOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SAFETY; EMBRYO; EMBRYOTOXICITY; FEMALE; FETOTOXICITY; FETUS; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MUTAGENICITY; NONHUMAN; PRENATAL DEVELOPMENT; RAT; REPEATED DRUG DOSE; SPRAGUE DAWLEY RAT; TOXICITY TESTING;

AND DEVELOPMENTAL TOXICITY STUDIES; APPETITE SUPPRESSANT; CARALLUMA FIMBRIATA; CHRONIC; GENOTOXICITY; NOEL; SAFETY ASSESSMENT;

ANIMALS; APPETITE DEPRESSANTS; ASCLEPIADACEAE; ETHANOL; FEMALE; MALE; MUTAGENICITY TESTS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PLANT EXTRACTS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SOLVENTS; TOXICITY TESTS, CHRONIC; WATER;

EID: 84887851187     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581813492827     Document Type: Article

References (45)

1. Gupta AK, Sharma M, Tandon N Reviews on Indian Medicinal Plants (Ca-Ce). Ca-Ce). New Delhi, India: Indian Council of Medical Research ; 2007 :
2. Ambasta SSP The Wealth of India: A Dictionary of Indian Raw Materials & Industrial Products: Raw Materials. Ca-Ci). New Delhi, India: Publications & Information Directorate (CSIR ; 1993 :
3. Dutt HC, Singh S, Avula B, Khan IA, Bedi YS. Pharmacological review of caralluma R.Br. with special reference to appetite suppression and anti-obesity. J Med Food. 2012 ; 15 (2). 108-119
4. Albers F, Meve U. Berlin (Germany): Springer-Verlag ; 2002: 5-8.
5. Deepak D, Khare A, Khare M. Review article number 49: plant pregnanes. Phytochemistry. 1989 ; 28 (12). 3255-3263
6. Abdel-Sattar E, Meselhy MR, Al-Yahya MA. New oxypregnane glycosides from Caralluma penicillata. Planta Med. 2002 ; 68 (5). 430-434
7. van Heerden FR, Marthinus Horak R, Maharaj VJ, Vleggaar R, Senabe JV, Gunning PJ. An appetite suppressant from Hoodia species. Phytochemistry. 2007 ; 68 (20). 2545-2553
8. MacLean DB, Luo LG. Increased ATP content/production in the hypothalamus may be a signal for energy-sensing of satiety: studies of the anorectic mechanism of a plant steroidal glycoside. Brain Res. 2004 ; 1020 (1-2). 1-11
9. Shukla YJ, Pawar RS, Ding Y, Li XC, Ferreira D, Khan IA. Pregnane glycosides from Hoodia gordonii. Phytochemistry. 2009 ; 70 (5). 675-683
10. Abdel-Sattar E, Ahmed AA, Hegazy ME, Farag MA, Al-Yahya MA. Acylated pregnane glycosides from Caralluma russeliana. Phytochemistry. 2007 ; 68 (10). 1459-1463
11. Abdel-Sattar E, Harraz FM, Al-ansari SM, et al. Acylated pregnane glycosides from Caralluma tuberculata and their antiparasitic activity. Phytochemistry. 2008 ; 69 (11). 2180-2186
12. Ahmad V. New pregnane glycosides from caralluma tuberculata. J Nat Prod. 1988 ; 51 (6). 1092-1097
13. Lin L, Lin L, Gil R, et al. Pregnane glycosides from caralluma umbellata. Phytochemistry. 1994 ; 35 (6). 1549-1553
14. Halim AF, Khalil AT. Pregnane glycosides from Caralluma retrospiciens. Phytochemistry. 1996 ; 42 (4). 1135-1139
15. Qiu S, Cordell G, Kumar B, et al. Bisdesmosidic pregnane glycosides from Caralluma lasiantha. Phytochemistry. 1999 ; 50 (1999). 485-491
16. Abdul-Aziz Al-Yahya M, Abdel-Sattar E, Guittet E.. Pregnane glycosides from Caralluma russeliana. J Nat Prod. 2000 ; 63 (10). 1451-1453
17. Abdel-Sattar E, Abdul-Aziz Al-Yahya M, Nakamura N, Hattori M.. Penicillosides A-C, C-15 oxypregnane glycosides from Caralluma penicillata. Phytochemistry. 2001 ; 57 (8). 1213-1217
18. Braca A, Bader A, Morelli I, et al. New pregnane glycosides from Caralluma negevensis. Tetrahedron. 2002 ; 58 (29). 5837-5848
19. Waheed A, Barker J, Barton SJ, et al. Novel acylated steroidal glycosides from Caralluma tuberculata induce caspase-dependent apoptosis in cancer cells. J Ethnopharmacol. 2011 ; 137 (3). 1189-1896
20. Avula B, Shukla YJ, Wang YH, Khan IA. Quantitative determination of pregnanes from aerial parts of Caralluma species using HPLC-UV and identification by LC-ESI-TOF. J AOAC Int. 2011 ; 94 (5). 1383-1390
21. Kunert O, Rao VG, Babu GS, et al. Pregnane glycosides from Caralluma adscendens var. fimbriata. Chem Biodivers. 2008 ; 5 (2). 239-250
22. Astell K, Mathai M, McAinch A, Stathis C, Su X. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial. Complement Ther Med. 2013 ; 21 (3). 180-189
23. Kuriyan R, Raj T, Srinivas SK, Vaz M, Rajendran R, Kurpad AV. Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women. Appetite. 2007 ; 48 (3). 338-344
24. Kamalakkannan S, Rajendran R, Venkatesh RV, Clayton P, Akbarsha MA. Antiobesogenic and antiatherosclerotic properties of caralluma fimbriata extract. J Nutr Metab. 2010 ; 285301: 2010
25. Kamalakkannan S, Rajendran R, Venkatesh R, Clayton P, Akbarsha M. Effect of caralluma fimbriata extract on 3T3-L1 pre-adipocyte cell division. Food Nutr Sci. 2011 ; 2011 (2). 329-336
26. Jagtap A, Shirke S, Patel M, et al. Toxicological evaluation of caralluma fimbriata extract in wistar rats. AAPS J. 2006 ;:
27. Venkatesh R, Rajendran R. Obesity: Epidemiology, Pathophysiology, and Prevention. Bagchi D Preuss H, ed. Boca Raton,: CRC Press ; 2007: 443-449.
28. Ames BN, McCann J, Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res. 1975 ; 31 (6). 347-364
29. Maron DM, Ames BN. Revised methods for the Salmonella mutagenicity test. Mutat Res. 1983 ; 113 (3-4). 173-215
30. Guideline for testing of chemicals: bacterial reverse mutation test (Section 4. No. 471, adopted. July 1997 ; 21: 1-11
31. -1-14.
32. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press ; 1996 :
33. -1-10.
34. -1-16.
35. 121-131.
36. -1-11.
37. 205-210.
38. Aleman CL, Mas RM, Rodeiro I, et al. Reference database of the main physiological parameters in Sprague-Dawley rats from 6 to 32 months. Lab Anim. 1998 ; 32 (4). 457-466
39. Kuroiwa Y, Hatayama K, Okazaki S. Biological Reference Data on CD(SD)IGS Rats-2002/2003. Maeda Y Shibuya K, ed. Yokahama, Japan: CD(SD)IGS Study Group ; 2002/2003: 61-72.
40. Usuda K, Abe M, Kubota R, Furukawa S. Biological Reference Data on CD(SD)IGS rats-2002/2003. Maeda Y Shibuya K, ed. Yokahama, Japan: CD(SD)IGS Study Group ; 2002/2003: 48-52.
41. Kurata M, Fukushima T, Yamasaki N, Iidaka T, Sasayama Y, Hamada Y. Biological Reference Data on CD(SD)IGS Rats-2002/2003. Maeda Y Shibuya K, ed. Yokahama, Japan: CD(SD)IGS Study Group ; 2002/2003: 27-34.
42. Bernardi C, Moneta D, Brughera M, et al. Haematology and clinical chemistry in rats: comparison of different blood collection sites. Comp Haematol Int. 1996 ; 6 (3). 160-166
43. Lillie LE, Temple NJ, Florence LZ. Reference values for young normal Sprague-Dawley rats: weight gain, hematology and clinical chemistry. Hum Exp Toxicol. 1996 ; 15 (8). 612-616
44. Petterino C, Argentino-Storino A. Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies. Exp Toxicol Pathol. 2006 ; 57 (3). 213-219
45. Naingade S, Jadhav A, Surve S. Caralluma fimbriata: an overview. IJPBS. 2013 ; 3 (1). 281-286